Form D · Biotechnology
Achaogen Inc
South San Francisco, CA · CIK 0001301501
Offering snapshot reported May 16, 2017 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 5, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 16, 2017 | Initial | $9,999,976 | No comparison | 1 | SEC filing |
| Jun 14, 2016 | Initial | $25,449,987 | No comparison | 8 | SEC filing |
| Mar 22, 2013 | Initial | $18,905,707 | No comparison | 15 | SEC filing |
| Apr 19, 2010 | Initial | $35,360,873 | No comparison | 15 | SEC filing |
| Oct 2, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-286870
Source: Form D, filed May 16, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jon B. Bruss | Executive |
| Alan B. Colowick | Director |
| Troy Cox | Director |
| John C. Doyle | Director |
| Becki Filice | Executive |
| Michael Fischbach | Director |
| Ian R. Friedland | Executive |
| Halley E. Gilbert | Director |
| Kenneth J. Hillan | Director, Executive |
| John F. Hollway | Executive |
| Dennis Hom | Executive |
| J. Kevin Judice | Director, Executive |
| Thomas King | Director |
| Kent E. Lieginger | Director |
| Gary Loeb | Executive |
| Robert More | Director |
| Heinz E. Moser | Executive |
| Kenneth Nussbacher | Director |
| Bryan E. Roberts | Director |
| Scott Rocklage | Director |
| Camille Samuels | Director |
| Zeryn Sarpangal | Executive |
| Tobin C. Schilke | Executive |
| John W. Smither | Director |
| Gregory Stea | Director |
| Lee Swem | Executive |
| Christopher T. Walsh | Director |
| Christine Welch | Executive |
| Blake Wise | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1 Tower Pl Suite 300
South San Francisco, CA, 94080
South San Francisco, CA, 94080